Prikaz rezultata 1 do 20 od 156
sledeće >
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
| 2022 | 1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Verschraegen, Claire; Andric, Zoran G   ; ...; (broj, koautora 20) | Konferencijski rad | |
| 2022 | A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry | Kaplon-Cieslicka, Agnieszka; ...; Seferovic, Petar M ; ...; (broj, koautora 20) | Article | |
| 2019 | A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A(3) adenosine receptor agonist (A(3)AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC). | Stemmer, Salomon M; Manojlovic, Nebojsa S ; ...; Natosevic, Sladjana; ...; (broj, koautora 20) | Konferencijski rad | |
| 2013 | A Phase3, Randomized, Double Blind, Placebo Controlled, Multi Center Study (Engage) to Investigate the Efficacy and Safety of Eliglustat in Patients with Gaucher Disease Type 1: 9 Month Results | Lukina, Elena; ...; Petakov, Marijana D; ...; (broj, koautora 20) | Konferencijski rad | |
| 2014 | A randomized double-blind phase III pivotal study of febuxostat (FEB) versus allopurinol (ALL) in the prevention of tumor lysis syndrome (TLS): Florence study. | Spina, Michele; ...; Ristic, Dusan J; ...; (broj, koautora 20) | Konferencijski rad | |
| 2025 | A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3. | Zhang, Jianjun; ...; Andric, Zoran ; ...; (broj, koautora 20) | Konferencijski rad | |
| 2013 | A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1). | Ramalingam, Suresh S; ...; Andric, Zoran G ; ...; Zaric, Bojan ; ...; Vukovic, Vojislav M; ...; (broj, koautora 20) | Konferencijski rad | |
| 2026 | Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC | Sliwa, Karen; ...; Seferovic, Petar ; ...; (broj, koautora 20) | Naučna kritika i polemika | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2026 | Access to molecular classification in endometrial cancer recommended by ESGO-ESTRO-ESP guidelines: multi-national survey in Eastern Europe | Abacjew-Chmylko, Anna; ...; Mandic, Aljosa ; ...; (broj, koautora 20) | Article | |
| 2025 | Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028 | Donia, M; ...; Kandolf, Lidija O; ...; (broj, koautora 20) | Article | |
| 2026 | Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028 (vol 10, 104295, 2025) | Donia, M; ...; Kandolf, L; ...; (broj, koautora 20) | Other | |
| 2018 | Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders (vol 39, pg 661, 2016) | Posset, Roland; ...; Vara, Roshni; (broj, koautora 20) | Other | |
| 2012 | ALTERNATIVE (EGF114299): A study of lapatinib, trastuzumab, and endocrine therapy in patients who received neo-/adjuvant trastuzumab (IV) and endocrine therapy | Gradishar, William John; ...; Neskovic-Konstantinovic, Zora B; ...; (broj, koautora 20) | Conference Paper | |
| 2024 | An Equal Seat at the Table: Exploring Videoconferencing with Shared Spatial Context combined with 3D Video Representations | Cashman, Thomas J; ...; Djordjevic, Milica; Dubajic, Goran; Marjanovic, Djordje; Okosanovic, Milena; Rankovic, Vukasin; Razumenic, Ivan; Rosko, Bojan; Sarkic, Teo;
Skakun, Marko; Stojanovic, Milos; Velickovic, Nikola; Jovanovic, Predrag; ...; (broj, koautora 20);
| Conference Paper | |
| 2017 | Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial | Vermeire, Severine; ...; Tarabar, Dino K; ...; (broj, koautora 20) | Article | |
| 2018 | Arterial Hypertension Is Prevalent in Pediatric Hemodialysis and Related to Dialysate Sodium Concentration and Weekly Dialysis Time -Data from the International Pediatric Hemodialysis Network (Iphn) | Borzych-Duzalka, Dagmara; ...; Kiuscic, Divna; ...; (broj, koautora 20) | Conference Paper | |
| 2025 | Assessing the reporting quality of educational interventions in trials on caregiver education for children with developmental disabilities using the GREET checklist: a meta-research study | Mahmic-Kaknjo, Mersiha; ...; Vucic, Vesna ; ...; Zuza, Prastalo Milena ; Veselinovic, Aleksandra; Pokimica, Biljana ; Ristic-Medic, Danijela ; ...; (broj, koautora 20) | Article | |
| 2022 | Association of multiple retinal nodular hamartomas and "confetti" skin lesions with end-stage renal disease in patients with tuberous sclerosis | Prelevic, Vladimir; ...; Simic-Ogrizovic, Sanja P ; Milinkovic, Marija MI; Azasevac, Tijana ; ...; (broj, koautora 20) | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2021 | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C | Dziadziuszko, R; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Konferencijski rad | |
| 2020 | Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100 | Grivas, P; ...; Radulovic, Sinisa S; ...; (broj, koautora 20) | Konferencijski rad | |